Medical News

RSS

Researcher isolates gene thought to play role in development of Alzheimer's disease

A team of international scientists, including a researcher from Simon Fraser University, has isolated a gene thought to play a causal role in the development of Alzheimer's disease. The Proceedings of the National Academy of Sciences recently published the team's study.

26 Feb 2014

Difference in interarm blood pressure linked to greater risk of future cardiovascular events

As heart disease continues to be one of the leading causes of death in the United States, practitioners and patients alike are looking for ways to cut risk factors and identify new clues to assist with early detection.

26 Feb 2014

Sinus and Allergy Center receives $8.4M NIH grant to help advance development of new treatments

The Northwestern Medicine- Sinus and Allergy Center has received a grant for more than $8.4 million from the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to help advance the understanding of chronic rhinosinusitis (CRS) and the development of new methods for its treatment over the next five years.

26 Feb 2014

Study links gambling and sexual behaviors in African-American adolescents

Late adolescence is a period when many youth become involved in high-risk behaviors with adverse consequences. Researchers at the Mailman School of Public Health with colleagues at Johns Hopkins University studied the degree to which two such behaviors, adolescent sexual behaviors and gambling, affected African American youth in nine primary schools in Baltimore, MD.

26 Feb 2014

Researcher identifies ''conductor'' in development of muscle tissue

A team led by Jean-Fran-ois C-t-, researcher at the IRCM, identified a ''conductor'' in the development of muscle tissue. The discovery, published online yesterday by the scientific journal Proceedings of the National Academy of Sciences (PNAS), could have an important impact on the treatment of muscular diseases such as myopathies and muscular dystrophies.

26 Feb 2014

Substance abuse worsens course of first-episode psychosis

Patients with first-episode psychosis who also present with substance abuse have a higher rate of hospitalisation after 12 months than their peers who do not, an Italian study reports.

25 Feb 2014

Psychoeducation reduces internalised stigmatisation in bipolar patients

A psychoeducation program designed to reduce internalised stigmatisation in patients with bipolar disease resulted in a significant decrease in total mean scores on the Internalized Stigmatization Scale of Mental Illness compared with a control group, a Turkish study shows.

25 Feb 2014

Unusual EGFR mutation should influence advanced NSCLC treatment choice

Non-small-cell lung cancer patients with very unusual epidermal growth factor receptor mutations may be more likely to be benefit from first-line chemotherapy than a tyrosine kinase inhibitor, research suggests.

25 Feb 2014

Sedentary behaviour has unclear link with prostate cancer risk

Sedentary behaviour is not a clearcut risk factor for prostate cancer, analysis of a large population-based cohort indicates.

25 Feb 2014

Detrusor muscle function declines with age

Detrusor muscle function and efficiency decline with increasing age, a urodynamic study of women with stress urinary incontinence indicates.

25 Feb 2014

Restless sleep predicts widespread pain in older adults

Non-restorative sleep appears to be a key factor associated with the likelihood of older adults developing widespread pain, study findings reveal.

25 Feb 2014

S. pneumoniae highly prevalent in urban Indonesians, especially children

Streptococcus pneumoniae is present in the nasopharyngeal mucosa in nearly half of children under the age of 5 years and one in 10 adults living in Java Island, Indonesia, a survey has found.

25 Feb 2014

Partial nephrectomy may offer younger renal cancer patients survival advantage

Partial nephrectomy may offer younger patients with localized renal cancer a distinct survival advantage compared with the complete removal of the kidney, US research suggests.

25 Feb 2014

Treatable factors linked to blood pressure variability in diabetes

Some factors that are associated with variability in home blood pressure in patients with Type 2 diabetes may be open to intervention, research suggests.

25 Feb 2014

Perioperative blood transfusion worsens kidney cancer patients’ survival

Patients who receive blood transfusions around the time of their surgery for nonmetastatic renal cell carcinoma have a worse chance of survival than those who do not, results of a large US study suggest.

25 Feb 2014

Understanding autism: an interview with Roberto Fernández Galán, PhD, Assistant Professor, Case Western Reserve School of Medicine

Autism does not come in just one flavour. It is a spectrum of disorders that share several features: impaired social interactions; impaired verbal and non-verbal communication; and restricted, repetitive behaviours.

25 Feb 2014

Murad launches Acne Spot Fast Fix and Acne Clearing Solution

Murad, Inc., the skincare brand synonymous with high-performance, science-based products, announced today the addition of two new products, Acne Spot Fast Fix and Acne Clearing Solution, which are proven to enhance the effectiveness of the company's already award-winning Acne line.

25 Feb 2014

DiFusion gets CE Mark, European clearance to market CleanFuze antimicrobial orthobiologic polymer

DiFusion Incorporated announced today that the company has received a CE Mark and European clearance to market and implant its new CleanFuze antimicrobial orthobiologic polymer. "We are extremely gratified to announce European clearance of our CleanFuze line of antimicrobial spinal implants. This material has been in development for over five years and attaining this milestone represents significant value for our shareholders," commented DiFusion Cofounder and CEO Derrick Johns.

25 Feb 2014

Seno Medical Instruments sells $34.6 million of $39 million Series C equity funding round

Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the process of diagnosing breast cancer, today announced that it has sold $34.6 million of a $39 million Series C equity funding round from existing investors with the lead investment from MedCare Investment Funds.

25 Feb 2014